Piraeus Medical

Piraeus Medical reports the first clinical cases using its **6Fr 70 NeuGlide catheter** in the US, following FDA clearance and commercial launch. The device expands the company’s neurointerventional access portfolio, complementing existing products like the **7Fr 87 NeuGlide+** and **8Fr 93 NeuFlex catheters**. The announcement highlights the catheter’s integration into clinical practice shortly after regulatory approval.

Oct 2026NeuroNews InternationalNews article

Piraeus Medical introduces its FDA-cleared **6-F 70 NeuGlide catheter** in the U.S., marking its first clinical deployments. The device targets neurovascular procedures, offering a smaller-profile alternative for physicians. The launch follows regulatory approval, expanding Piraeus Medical’s portfolio in interventional neurology.

Sep 2026Endovascular TodayNews article

Piraeus Medical launches the **6F 70 NeuGlide catheter** in the US, marking its first commercial cases after receiving **FDA clearance**. The product expands the company’s neurointerventional access portfolio, complementing existing offerings like the **7F 87 NeuGlide+™** and **8F 93 NeuFlex™ catheters**. The new device supports minimally invasive procedures in neurosurgery and interventional radiology.

Sep 2026EIN PresswireNews article

Minnesota’s medical device startups raised over $100 million in March 2026, leading the state’s funding activity. The surge highlights growth in the medtech sector, driven by emerging startups and innovations. Key players in the ecosystem are securing significant investments amid a broader push for healthcare technology solutions.

Apr 2026Next in the NorthNews article